Newswise — LOUISVILLE, Ky. – Use of irreversible electroporation (IRE) doubles the survival time for patients with locally advanced pancreatic cancer say researchers at the University of Louisville in a paper in the September edition of the Annals of Surgery (http://journals.lww.com/annalsofsurgery/Abstract/2015/09000/Treatment_of_200_Locally_Advanced__Stage_III_.10.aspx).
“The appropriate and precise use of IRE in appropriately selected patients with locally advanced pancreatic cancer can result in a median overall survival close to 24 months, which is nearly double the survival rate with the best new chemotherapy and chemo-radiotherapy,” said Robert C. G. Martin, II, M.D., Ph.D., director of surgical oncology at UofL.

http://www.newswise.com/articles/view/638988/?sc=sphn

Focused Electrical Blasts Significantly Increase Survival for Patients with Pancreatic Cancer